Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Society matters LIVE: Lab made meat on the menu?
• Research at Aston University focuses on both creating lab-based meat and its psychological acceptance • Dr Eirini Theodosiou and Dr Jason Thomas will be speaking at April’s Society matters LIVE event • Lab made meat on the menu? will take place at Cafe Artum in Hockley Social Club on Thursday 27 April. Lab made meat will be the topic of the latest Society matters LIVE event from Aston University at Café Artum at Birmingham’s Hockley Social Club on Thursday 27 April. Dr Eirini Theodosiou and Dr Jason Thomas at Aston University are conducting research into lab-made or cultivated meat, both exploring the creation of the meat and the psychological impact of the product. Dr Eirini Theodosiou, senior lecturer in the School of lnfrastructure and Sustainable Engineering, focuses on ways to produce enough cell mass to create the meat. Meanwhile Dr Jason Thomas’ work explores the psychology behind supporting people to accept lab-made food. The research comes as current trends indicate that demand for animal-based foods will increase by 70% in 2050 to feed the predicted 9.8 billion people. Dr Theodosiou said: “Cultivated or lab grown meat offers a safer, more sustainable and animal cruelty-free alternative for consumers. It is a very young industry trying to replace traditional meat production methods however, with 800 million people worldwide suffering from hunger and malnutrition, it is a viable option.” “In addition, the livestock industry is responsible for 12-18% of the total greenhouse gas emissions and is a cause of deforestation. Increased meat production and factory farming are the topmost likely causes of the next pandemic due to the extensive use of antibiotics and increasing emergence of zoonotic diseases.” Dr Thomas said: “It is a relatively new food technology, and much work still needs to be done to make it affordable and on a massive scale. We are interested in finding out what factors can influence consumer purchase of and consumption of lab-made meat.” The event is organised by Aston University and Café Artum at Hockley Social Club as part of the Society matters LIVE series. Free tickets are available at https://www.eventbrite.co.uk/e/lab-made-meat-on-the-menu-tickets-464161147487?aff=ebdsoporgprofile
Discovery may lead to more precise treatments for advanced colorectal cancer Researchers at ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute have demonstrated for the first time that microRNA (miRNA) expression leads to a diversity of cancer stem cells within a colorectal cancer tumor. This diversity of cancer cells may explain why advanced colorectal cancer is difficult to treat. Study results have been in the Journal of Stem Cell Research and Therapy. The findings broaden the understanding of how miRNA expression adds to cancer stem cell diversity and may lead to more precise anti-cancer treatments for patients with advanced colorectal cancer. The research builds on prior discoveries by scientists at the Graham Cancer Center about how cancer stem cell activity contributes to the development and spread of colorectal cancer. “Our research shows — at least in the laboratory — that there are different subpopulations of cancer stem cells in a tumor, and they may be driving the growth of the cancer,” said Principal Investigator Bruce Boman, M.D., Ph.D., MSPH, FACP, medical director of Cancer Genetics and Stem Cell Biology at the Graham Cancer Center. “In one subpopulation of cancer stem cells, its miRNA will shut down the stem cell genes that are expressed in another subpopulation, and vice versa, within the same tumor.” From left: ChristianaCare researchers Lynn Opdenaker, Ph.D., Brian Osmond, Bruce Boman, M.D., Ph.D., Chi Zhang, Victoria Hunsu, Caroline Facey, Ph.D. Not pictured Victoria Stark, MS. The study focused on the composition of cancer stem cells within a colorectal cancer cell line (HT29) in the laboratory setting. Researchers evaluated the different cancer stem cell subpopulations that were identified by examining patterns of miRNA expression in each subpopulation and looking for differences. The researchers found that each of the four diverse subpopulations that were studied (ALDH, LRIG1, CD166 and LGR5) had a different miRNA expression or gene signature. The researchers found that miRNA expression could inhibit the expression of messenger RNA (mRNA), which carries instructions from the DNA to encode specific proteins within cells. Therefore, miRNA, by controlling gene expression, dictate which proteins are contained in the stem cells. The researchers discovered the miRNA that are upregulated in certain cancer stem cell subpopulations are downregulated in other cancer stem cell subpopulations. In this way, differential miRNA expression leads to cancer stem cell heterogeneity within colorectal tumor tissue. “It’s an early research finding and needs to be followed up with other experiments, but it has clear relevance to the clinic,” Boman said. “The question is: Can you target the miRNA to make cancer more sensitive to certain treatments? Because we know what the current anti-cancer treatments are targeting, we may be able to modulate or manipulate the cancer, so it becomes more sensitive to the treatment.” Identification of a network of genes regulated by microRNAs in a cancer stem cell subpopulation. For more than a decade, ChristianaCare’s researchers have contributed to the understanding of the role that cancer stem cells and miRNA expression play in the development and spread of colorectal cancer. This latest finding builds on earlier discoveries that examined a link between two cellular signaling pathways: retinoic acid (RA) signaling and wingless-related integration site (WNT) signaling, which are dysregulated by different gene mutations in colorectal tumors. The RA signaling pathway induces growth arrest and differentiation of cancer stem cells. Notably, retinoic acid is effective against other types of cancer such as leukemia. The role of the WNT signaling pathway has an opposite effect on tumor growth. The WNT signaling pathway is activated by a mutation in the APC (adenomatous polyposis coli) gene in about 90% of cases of colorectal cancer. In APC mutant tissue, dysregulated miRNA expression may underlie an imbalance between the RA and WNT signaling, which then leads to intratumoral cancer stem cell heterogeneity. Still, this mechanism that may enable the cancer to proliferate could also provide clues on how to more effectively treat cancer. “If you’ve got an imbalance between these two signaling pathways, then you’ve likely got a growth driver,” Boman said. “The question is: Can you suppress the WNT signaling and enhance the retinoic acid signaling?” It may be possible to increase the sensitivity of colorectal cancer to retinoic acid-type drugs, and therapeutically shift the balance between different cancer stem cell subpopulations, thereby suppressing cancer growth. More research is needed to determine how targeted cancer therapies containing retinoic acid-type drugs may be made more effective against advanced cancer. This research will be presented at the annual meeting of the American Association for Cancer Research in Orlando, Florida, April 14-19. This research project was supported by a grant from the Lisa Dean Moseley Foundation.
UC Irvine NATO expert available to discuss Finland membership
Heidi Hardt, associate professor of political science at UC Irvine, is a scholar whose expertise is in transatlantic security, US foreign policy, national security and European security and defense, including NATO, the EU and OSCE. She is the author of the book, NATO's Lessons in Crisis: Institutional Memory in International Organizations (Oxford UP, 2018). She recently completed a 2021-2022 Council on Foreign Relations International Affairs Fellowship for Tenured International Relations Scholars (IAF-TIRS). During the year, she worked for the US State Department (NATO Desk). Professor Hardt can be reached via email at hhardt@uci.edu.
• Professor Patricia Thornley welcomes latest UK energy security plans • But calls for more exploration of bioenergy with carbon capture and storage • She believes plans shouldn’t concentrate solely on energy such as wind and solar power. A leading biomass scientist at Aston University has welcomed the government’s announcement to ensure UK energy is more secure. However, Professor Patricia Thornley, director of Aston University’s Energy and Bioproducts Research Institute (EBRI), believes the government shouldn’t just concentrate on energy such as wind and solar power. She is calling for the government to explore the use of power bioenergy with carbon capture and storage (or power BECCS). On 30 March the Department for Energy Security and Net Zero published the Powering Up Britain: Net Zero Growth Plan, and the Powering Up Britain: Energy Security Plan to set out steps to make the UK more energy independent, secure and resilient. Professor Thornley believes that the UK’s carbon reduction targets could be tackled by delivering negative emission BECCS projects. The process uses sustainable biomass and waste materials to generate electricity in combination with carbon capture and permanent storage. Through this physical removal of greenhouse gases from the atmosphere, power BECCS is able to deliver negative emissions. Professor Thornley said: “It is wonderful to see the government moving forward with its carbon reduction plans, whilst recognising the scale of the challenge faced. “Bioenergy is delivering carbon reductions around the UK today - 62% of our renewable energy and around 13% of our electricity comes from biomass - and developing sustainable biomass conversion with carbon capture and storage (CCS) would be a natural progression for the UK. “So it is good to see commitment to CCS, but to fully leverage the UK’s negative emission potential we need BECCS technology to be rapidly deployed.” EBRI and the Supergen Bioenergy hub, which is led by Aston University, are working on applied research to progress this ambition. Professor Thornley added: “Our research at Aston University has demonstrated the potential for sustainable BECCS facilities to deliver a substantial proportion of UK required negative emissions but that the exact amount of negative emissions achieved can vary hugely with plant design and operational choices. So we hope to use our knowledge and research outputs to support UK deployment of sustainable bioenergy moving forward.“ As well as her research at Aston University, Professor Thornley has been contributing her expertise to a government working group exploring the sustainable use of biomass for two years. ENDS
Aston University establishes new independent investment company
Aston University is part of a group of eight universities which has established a new investment company Midlands Mindforge will accelerate the commercialisation of university research It aims to raise up to £250 million from investors. Aston University is one of eight research intensive universities in the Midlands to establish a new investment company to accelerate the commercialisation of university spinouts and early-stage IP rich businesses in the region. Midlands Mindforge Limited has been co-founded by Aston University, University of Birmingham, Cranfield University, Keele University, University of Leicester, Loughborough University, University of Nottingham and University of Warwick, collectively Midlands Innovation. This ambitious, patent capital investment company plans to raise up to £250 million from strategic corporate partners, institutional investors and qualifying individuals. It aims to transform ground-breaking science and technology into successful businesses with real-world impact. Midlands Mindforge will help to address the significant funding deficit for early-stage technology businesses in the region. Through the combination of additional capital and company-building skills, Midlands Mindforge will lay the foundations of a more vibrant ecosystem for emerging science-backed companies in areas such as Clean Technology, AI and Computational Science, Life Sciences and Health Tech. Professor Aleks Subic, Vice-Chancellor of Aston University, said: "Aston University has a strong track record in bringing together industry and academia to solve real world problems and drive innovation through applied and translational research. Â Investment raised through Midlands Mindforge will enable a step change that will ensure we get the very best outcomes for our research. "The impact of increased investment in research translation will be felt widely, with Midlands Mindforge supporting the growth of high value added businesses and jobs in the region and creating the right conditions to build future global companies. This is a hugely exciting time for Aston University and the wider Midlands Innovation group of universities, and I look forward to seeing the benefits that this strategic development will bring." Collectively, the eight founding universities have the most postgraduate students, the highest levels of annual income, more research disclosures and patents generated per unit of research spend in the last three years, in comparison to any other UK university grouping. Minister of State for Science, Research & Innovation George Freeman MP said: "Commercialising UK science & technology for global industrial adoption has never been more urgent for both the UK economy and the global resource challenges facing us. The Midlands Innovation universities are driving a new era of innovation from robotics and advanced manufacturing to life science and autonomous vehicles and much more. "As we in Government increase UK public R&D to a record £20 billion a year, the key is private finance backing spinouts and scale-ups. The Midlands is rapidly becoming a world class UK cluster of excellence and Midlands Mindforge will play a key role in bringing global investors to help back world class companies." Chairman of the Midlands Engine Partnership, Sir John Peace, said: "The Midlands has always been associated with exceptional invention and creativity, but has long experienced significant underinvestment and consequently productivity levels have lagged behind the rest of the UK. "This bold and ambitious initiative led by the Midlands Innovation universities has the potential to help close the investment gap, supporting our region to reach its true potential for sustainable economic growth. Midlands Mindforge will help to further fast-track commercialisation of research ideas, creating a more resilient economy and playing an important role in levelling up the Midlands." Andy Street, Mayor of the West Midlands, said: "A key part of my mayoral mission is to drive our regional recovery forward and help generate the high-quality jobs of the future in order to improve quality of life for local people. This exciting new investment vehicle will very much support that mission planting the seeds for long-term sustainable economic growth here in the West Midlands. "Many brilliant ideas and top businesses have spun out from Midlands universities and this new venture will help us to advance that agenda and retain more of our innovative success stories within our region. "Together we can better nurture the enterprising talent on our doorstep and this new endeavour creates a wonderful opportunity to do just that." For more information about Midlands Mindforge visit www.midlandsmindforge.com
Ask an Expert: Is the "AI Moratorium" too far reaching?
Recent responses to chatGPT have featured eminent technologists calling for a six-month moratorium on the development of “AI systems more powerful than GPT-4.” Dr. Jeremy Kedziora, PieperPower Endowed Chair in Artificial Intelligence at Milwaukee School of Engineering, supports a middle ground approach between unregulated development and a pause. He says, "I do not agree with a moratorium, but I would call for government action to develop regulatory guidelines for AI use, particularly for endowing AIs with actions." Dr. Kedziora is available as a subject matter expert on the recent "AI moratorium" that was issued by tech leaders. According to Dr. Kedziora: There are good reasons to call for additional oversight of AI creation: Large deep or reinforcement learning systems encode complicated relationships that are difficult for users to predict and understand. Integrating them into daily use by billions of people implies some sort of complex adaptive system in which it is even more difficult for planners to anticipate, predict, and plan. This is likely fertile ground for unintended – and bad – outcomes. Rather than outright replacement, a very real possibility is that AI-enabled workers will have sufficiently high productivity that we’ll need less workers to accomplish tasks. The implication is that there won’t be enough jobs for those who want them. This means that governments will need to seriously consider proposals for UBI and work to limit economic displacement, work which will require time and political bargaining. I do not think it is controversial that we would not want a research group at MIT or CalTech, or anywhere developing an unregulated nuclear weapon. Given the difficulty in predicting its impact, AI may well be in the same category of powerful, suggesting that its creation should be subject to the democratic process. At the same time, there are some important things to keep in mind regarding chatGPT-like AI systems that suggest there are inherent limits to their impact: Though chatGPT may appear–at times–to pass the famous Turing test, this does not imply these systems ’think,’ or are ’self-aware,’ or are ’alive.’ The Turing test aims to avoid answering these questions altogether by simply asking if a machine can be distinguished from a human by another human. At the end of the day, chatGPT is nothing more than a bunch of weights! Contemporary AIs–chatGPT included–have very limited levers to pull. They simply can’t take many actions. Indeed, chatGPT’s only action is to create text in response to a prompt. It cannot do anything independently. Its effects, for now, are limited to passing through the hands of humans and to the social changes it could thereby create. The call for a moratorium emphasizes ‘control’ over AI. It is worth asking just what this control means. Take chatGPT as an example–can its makers control responses to prompts? Probably only in a limited fashion at best, with less and less ability as more people use it. There simply aren’t resources to police its responses. Can chatGPT’s makers ‘flip the off switch?’ Absolutely – restricting access to the API would effectively turn chatGPT off. In that sense, it is certainly under the same kind of control humans subjected to government are. Keep in mind that there are coordination problems – just because there is an AI moratorium in the US does not mean that other countries–particularly US adversaries– will stop development. And as others have said: “as long as AI systems have objectives set by humans, most ethics concerns related to artificial intelligence come from the ethics of the countries wielding them.” There are definitional problems with this sort of moratorium – who would be subject to it? Industry actors? Academics? The criterion those who call for the moratorium use is “AI systems more powerful than GPT-4.” What does “powerful” mean? Enforcement requires drawing boundaries around which AI development is subject to a moratorium – without those boundaries how would such a policy be enforced? It might already be too late – some already claim that they’ve recreated chatGPT. There are two major groups to think about when looking for develop regulatory solutions for AI: academia and industry. There may already be good vehicles for regulating academic research, for example oversight of grant funding. Oversight of AI development in industry is an area that requires attention and application of expertise. If you're a journalist covering Artificial Intelligence, then let us help. Dr. Kedziora is a respected expert in Data Science, Machine Learning, Statistical Modeling, Bayesian Inference, Game Theory and things AI. He's available to speak with the media - simply click on the icon now to arrange an interview today.
Aston University and asbestos consultancy to use AI to improve social housing maintenance
• Aston University and Thames Laboratories enter 30-month Knowledge Transfer Partnership • Will use machine-learning and AI to create a maintenance prioritisation system • Collaboration will reduce costs, emissions, enhance productivity and improve residents' satisfaction. Aston University is teaming up with asbestos consultancy, Thames Laboratories (TL) to improve efficiency of social housing repairs. There are over 1,600 registered social housing providers in England, managing in excess of 4.4 million homes. Each of these properties requires statutory inspections to check gas, asbestos and water hygiene, in addition to general upkeep. However, there is not currently a scheduling system available that offers integration between key maintenance and safety contractors, resulting in additional site visits and increased travel costs and re-work. Aston University computer scientists will use machine-learning and AI to create a maintenance prioritisation system that will centralise job requests and automatically allocate them to the relevant contractors. The collaboration is through a Knowledge Transfer Partnership (KTP) - a collaboration between a business, an academic partner and a highly-qualified researcher, known as a KTP associate. This partnership builds on the outcomes of TL’s first collaboration with Aston University, by expanding the system developed for the company’s in-house use - which directs its field staff to jobs. The project team will improve the system developed during the current KTP to enable it to interact with client and contractor systems, by combining an input data processing unit, enhanced optimisation algorithms, customer enhancements and third-party add-ons into a single dynamic system. The Aston University team will be led by Aniko Ekart, professor of artificial intelligence. She said: “It is a privilege to be involved in the creation of this system, which will select the best contractor for each job based on their skill set, availability and location and be reactive to changing priorities of jobs." TL, based in Fenstanton, just outside Cambridge, provides asbestos consultancy, project management and training to businesses, local authorities, social housing and education facilities, using a fleet of mobile engineers across the UK. John Richards, managing director at Thames Laboratories, said: “This partnership will allow us to adopt the latest research and expertise from a world-leading academic institute to develop an original solution to improving the efficiency of social housing repairs, maintenance and improvements to better meet the needs of social housing residents.” Professor Ekart will be joined by Dr Alina Patelli as academic supervisor. Dr Patelli brings experience of software development in the commercial sector as well as expertise in applying optimisation techniques with focus on urban systems. She said: “This is a great opportunity to enhance state-of-the-art optimisation and machine learning in order to fit the needs of the commercial sector and deliver meaningful impact to Thames Laboratories.”
Expert comment available Powering up Britain new policy paper
Powering up Britain policy paper The government has this morning announced policy plans to improve the UK’s energy security, economic opportunities of the transition, and achieve its net zero commitments. Professor Patricia Thornley director of Aston University’s Energy and Bioproducts Research Institute (EBRI) is available to explain what this is and how it could affect our lives. Professor Thornley is an expert in the use of power bioenergy with carbon capture and storage (power BECCS). For further details contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
ChristianaCare Will Open Neighborhood Hospital at Its West Grove Campus
Plans for emergency and inpatient care follow extensive planning and community listening sessions ChristianaCare today provided new details about its plans to restore needed health care services to the southern Chester County, Pennsylvania, community at its West Grove campus, formerly Jennersville Hospital. ChristianaCare will open a neighborhood hospital that includes 10 emergency department beds and 10 inpatient beds. The neighborhood hospital will offer emergency care and behavioral health emergency care and provide diagnostic capabilities including ultrasound, computed tomography (CT), X-ray and laboratory services. The emergency department will treat common emergency care needs such as falls, injuries, heart attacks and strokes. Additionally, the hospital will benefit from access to ChristianaCare’s large network of specialists and support services — such as neurology and cardiology — through virtual consults. “We are excited to share our plans to restore important local health care resources to the southern Chester County community,” said Janice Nevin, M.D., MPH, ChristianaCare president and CEO. “We are committed to our neighbors in southern Chester County for the long-term, serving them as expert, caring partners in their health.” ChristianaCare’s plans for a neighborhood hospital meet the Pennsylvania Department of Health’s requirements for a micro-hospital, which must have a minimum of 10 inpatient beds and 10 emergency department treatment rooms and offer imaging services on-site. “After listening to the needs of the community and an extensive review of historical and projected demographic data, we believe this neighborhood hospital model will provide the right mix of health care services for the West Grove campus in a way that is sustainable and meets the community’s most immediate needs today,” said Heather Farley, M.D., chief wellness officer for ChristianaCare and the clinical leader for the West Grove planning. “It also sets us up to grow in meeting more of the community’s needs in the future.” ChristianaCare anticipates an opening date in late 2024, although the date is subject to change due to the significant work that will be required to renovate the facility to bring it up to current standards, including the build-out of an entirely new information technology infrastructure. Last year, ChristianaCare received funding from Chester County and the Commonwealth of Pennsylvania totaling $5 million to assist in facility upgrades. ChristianaCare already serves residents of southern Chester County. Since 2020, ChristianaCare has provided primary care in three practices that are located in Jennersville, West Grove and Kennett Square. The West Grove practice has recently brought on additional providers and will soon begin offering virtual visits with ChristianaCare specialists. Combined, these three practices are now the “medical home” for 22,000 residents in these communities. ChristianaCare finalized the purchase of its West Grove campus from Tower Health in June 2022. The hospital has been closed since Dec. 31, 2021.
How Teleradiology Improves ER Efficiency & Patient Care
Is your ER efficiency where you need it to be? Learn how radiology collaboration services from RealTime Medical have improved ER efficiency and patient care from Tabitha Kearney, VP Clinical Services, Deep River & District Hospital. Learn how radiology collaboration services have improved ER efficiency and patient experience from Tabitha Kearney, VP Clinical Services, Deep River & District Hospital. Learn more here: https://realtimemedical.com/radiology-services/ #radiology #teleradiology #diagnosticimaging
